Summary
Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Teleflex Incorporated ( TFX ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Great. Thanks for joining us here for our next session.
Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock
Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript
Teleflex Incorporated ( TFX ) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business November 14, 2025 8:00 AM EST Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy Development Thierry Glauser Christopher Buller Liam Kelly - Chairman, President & CEO Conference Call Participants Kevin Croce Elliot Smith Patrick Wood - Morgan Stanley, Research Division Ravi Misra - Truist Securities, Inc., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Vascular Intervention Investor Meeting. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.
Teleflex Incorporated (TFX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Teleflex Incorporated ever had a stock split?
Teleflex Incorporated Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Liam J. Kelly CEO | NYSE Exchange | 879369106 CUSIP |
| US Country | 14,100 Employees | 14 Nov 2025 Last Dividend | 17 Jun 1997 Last Split | 18 Feb 1988 IPO Date |
Overview
Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.
Products and Services
- Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
- Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
- Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
- Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
- Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
- Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
- Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
- Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.
Contact Information
